⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL27486679 | 0.93 | CRBN (0.45) | — | |
| Phosphoric Acid SCHEMBL3626803 | 0.87 | CRBN (0.41) | — | |
| Diacetamide SCHEMBL28386543 | 0.80 | FFAR3 (0.58) | — | |
| Diacetamide SCHEMBL29069322 | 0.80 | FFAR3 (0.58) | — | |
| Acetic Acid SCHEMBL8393359 | 0.80 | FFAR3 (0.58) | — | |
| Diacetamide SCHEMBL97089 | 0.79 | — | — | |
| Diacetamide SCHEMBL635653 | 0.77 | FFAR3 (0.54) | — | |
| Diacetamide SCHEMBL29227698 | 0.77 | FFAR3 (0.54) | — | |
| Diacetamide SCHEMBL29227696 | 0.77 | FFAR3 (0.54) | — | |
| Diacetamide SCHEMBL27620016 | 0.77 | CRBN (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 210 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112384509-B | Furin inhibitors | 葛兰素史密斯克莱知识产权发展有限公司 | 2024-04-30 | — | — | CN | claimed |
| EP-3790871-B1 | FURIN INHIBITORS | GLAXOSMITHKLINE IP DEV LTD (GB) | 2024-01-24 | — | — | EP | claimed |
| CN-114929220-A | Small molecule furin inhibitors for the treatment of infectious diseases | BP资产V股份有限公司 | 2022-08-19 | — | — | CN | claimed |
| CN-112384509-A | Furin inhibitors | 葛兰素史密斯克莱知识产权发展有限公司 | 2021-02-19 | — | — | CN | claimed |
| CN-1527831-A | Antagonists of MCP-q function and method of use thereof | ̩ | 2004-09-08 | — | — | CN | claimed |
| EP-0874809-B1 | CARBAMOYLOXY DERIVATIVES OF MUTILINE AND THEIR USE AS ANTIBACTERIALS | SMITHKLINE BEECHAM PLC (GB) | 2003-08-27 | — | — | EP | claimed |
| EP-1175209-A2 | USE OF ANTIEPILEPTICS FOR TREATING RESPIRATORY DISORDERS, IN PARTICULAR ASTHMATIC DISORDERS | Lomia, Merab (GE) | 2002-01-30 | — | — | EP | claimed |
| US-6239175-B1 | Carbamoyloxy derivatives of mutiline and their use as antibacterials | SMITHKLINE BEECHAM P.L.C. (GB) | 2001-05-29 | — | — | US | claimed |
| WO-2000066096-A2 | USE OF ANTIEPILEPTICS FOR TREATING RESPIRATORY DISORDERS, IN PARTICULAR ASTHMATIC DISORDERS | LOMIA MERAB (GE) | 2000-11-09 | — | — | WO | claimed |
| CN-1239473-A | Method of preparing amino carboxylic acids | MONSANTO CO (US) | 1999-12-22 | — | — | CN | claimed |
| US-5254679-A | Containing a quaternized nitrogen | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-10-19 | — | — | US | claimed |
| US-5212069-A | Forming dipeptides from amides and glycine, cysteine or methionine | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1993-05-18 | — | — | US | claimed |
| US-5134073-A | Culture product of zoogloea ramigera | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1992-07-28 | — | — | US | claimed |
| US-5049558-A | Quaternized nitrogen-heterocycle substituted | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1991-09-17 | — | — | US | claimed |
| EP-0164944-B1 | CEPHALOSPORIN DERIVATIVES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1990-07-11 | — | — | EP | claimed |
| US-4909916-A | Method of working up the solution from the enzymatic resolution of a racemate of an N-acetyl-DL-amino-carboxylic acid | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1990-03-20 | — | — | US | claimed |
| EP-0232486-B1 | PROCESS FOR REPROCESSING THE SOLUTION WHICH IS LEFT AFTER THE REMOVAL OF THE ENZYMES UPON THE ENZYMATIC RACEMATIC SPLITTING OF AN N-ACETYL-DL-AMINO ACID IN THE PRESENCE OF AN L-AMINO ACID ACYLASE | Degussa Aktiengesellschaft (DE) | 1989-09-06 | — | — | EP | claimed |
| EP-0164944-A1 | Cephalosporin derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1985-12-18 | — | — | EP | claimed |
| US-4410522-A | BACTERICIDES | TOYAMA CHEMICAL CO., LTD. (JP) | 1983-10-18 | — | — | US | claimed |
| JP-11180801-A | — | — | None | — | — | JP | disclosed |
| EP-3450953-B1 | COMPOSITION FOR PREPARING BIOLOGICAL MATERIAL HAVING EXCELLENT LIGHT TRANSMISSIVITY AND USE OF COMPOSITION | RIKEN (JP) | 2025-11-19 | — | — | EP | disclosed |
| US-20250179066-A1 | ZWITTERIONIC ANTIBACTERIAL COMPOUNDS | HOFFMANN-LA ROCHE INC. (US) | 2025-06-05 | — | — | US | disclosed |
| US-12292363-B2 | Method for preparing biological material having excellent light-transmitting property | RIKEN (JP) | 2025-05-06 | — | — | US | disclosed |
| CN-119876199-A | Application of northeast wood frog lysozyme gene, mature polypeptide region gene, recombinant protein and recombinant lysozyme gene engineering bacteria | 哈尔滨师范大学 | 2025-04-25 | — | — | CN | disclosed |
| CN-119730847-A | NRF2 protein degradation agent | 盖尼米德肿瘤学股份有限公司 | 2025-03-28 | — | — | CN | disclosed |
| US-20240417387-A1 | SULFONYLPIPERAZINYL COMPOUNDS FOR TREATMENT OF BACTERIAL INFECTIONS | HOFFMANN-LA ROCHE INC. (US) | 2024-12-19 | — | — | US | disclosed |
| CN-118754943-A | Fermented milk-derived polypeptide with prebiotic characteristics and preparation method thereof | 宁波大学 | 2024-10-11 | — | — | CN | disclosed |
| CN-118584751-A | POSS-based positive photoresist composition for organic insulating film | 烟台希尔德材料科技有限公司 | 2024-09-03 | — | — | CN | disclosed |
| CN-114350694-B | L-ornithine producing strain and construction method thereof | 新泰市佳禾生物科技有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-112384509-B | Furin inhibitors | 葛兰素史密斯克莱知识产权发展有限公司 | 2024-04-30 | — | — | CN | disclosed |
| WO-2023215378-A1 | METHODS OF TREATING FIBROSIS | ATHIRA PHARMA, INC. (US) | 2023-11-09 | — | — | WO | disclosed |
| CN-116855484-A | Phage lyase Lysrb9 and encoding gene thereof and application thereof in removal of SRB biofilm | 陕西生化产业技术创新平台有限公司 | 2023-10-10 | — | — | CN | disclosed |
| CN-116536412-A | Biomarker PGLYRP2 and application of kit thereof | 山东中医药大学附属医院 | 2023-08-04 | — | — | CN | disclosed |
| WO-2023107597-A2 | BICYCLIC HETEROAROMATIC AMIDE COMPOUNDS AND USES THEREOF | Kineta, Inc. (US) | 2023-06-15 | — | — | WO | disclosed |
| US-11656159-B2 | Composition for preparing biological material having excellent light transmissivity and use of composition | RIKEN (JP) | 2023-05-23 | — | — | US | disclosed |
| CN-115943992-A | Preparation method and application of perilla alcohol extract composite edible emulsion | 南京工业大学 | 2023-04-11 | — | — | CN | disclosed |
| US-20220381657-A1 | METHOD FOR PREPARING BIOLOGICAL MATERIAL HAVING EXCELLENT LIGHT-TRANSMITTING PROPERTY | RIKEN (JP) | 2022-12-01 | — | — | US | disclosed |
| CN-114751920-A | Antitumor compounds | 法马马有限公司 | 2022-07-15 | — | — | CN | disclosed |
| WO-2022127779-A1 | SUBSTITUTED PYRIDAZINONE COMPOUND AND USE THEREOF | 山东第一医科大学(山东省医学科学院) | 2022-06-23 | — | — | WO | disclosed |
| CN-114350694-A | L-ornithine producing strain and construction method thereof | 新泰市佳禾生物科技有限公司 | 2022-04-15 | — | — | CN | disclosed |
| CN-113874016-A | Compound and use thereof | 福宏治疗公司 | 2021-12-31 | — | — | CN | disclosed |
| CN-112384509-A | Furin inhibitors | 葛兰素史密斯克莱知识产权发展有限公司 | 2021-02-19 | — | — | CN | disclosed |
| CN-112236172-A | Methods and compounds for treating disorders | 福宏治疗公司 | 2021-01-15 | — | — | CN | disclosed |
| EP-3724192-A1 | TRIAZOLOBENZAZEPINES AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS | Richter Gedeon Nyrt. (HU) | 2020-10-21 | — | — | EP | disclosed |
| WO-2019116324-A1 | TRIAZOLOBENZAZEPINES AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS | RICHTER GEDEON NYRT. (HU) | 2019-06-20 | — | — | WO | disclosed |
| US-20190086302-A1 | COMPOSITION FOR PREPARING BIOLOGICAL MATERIAL HAVING EXCELLENT LIGHT TRANSMISSIVITY AND USE OF COMPOSITION | RIKEN (JP) | 2019-03-21 | — | — | US | disclosed |
| US-10227330-B2 | Diaminopyrimidine derivatives and processes for the preparation thereof | YUHAN CORPORATION (KR) | 2019-03-12 | — | — | US | disclosed |
| US-20180265547-A1 | Z-SELECTIVE OLEFIN METATHESIS OF PEPTIDES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2018-09-20 | — | — | US | disclosed |
| US-20180111918-A1 | DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF | YUHAN CORPORATION (KR) | 2018-04-26 | — | — | US | disclosed |
| US-9890138-B2 | Diaminopyrimidine derivatives and processes for the preparation thereof | YUHAN CORPORATION (KR) | 2018-02-13 | — | — | US | disclosed |
| US-9811014-B2 | Yellow toner and production method therefor | CANON KABUSHIKI KAISHA (JP) | 2017-11-07 | — | — | US | disclosed |
| EP-3196236-A1 | VERTICAL ALIGNMENT FILM COMPRISING (CO)POLYMER OF CYCLIC OLEFIN COMPOUND | LG Chem, Ltd. (KR) | 2017-07-26 | — | — | EP | disclosed |
| US-9701146-B2 | Ink set and thermal transfer recording sheet | CANON KABUSHIKI KAISHA (JP) | 2017-07-11 | — | — | US | disclosed |
| US-9676676-B2 | Selective olefin metathesis with cyclometalated ruthenium complexes | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2017-06-13 | — | — | US | disclosed |
| EP-2875034-B1 | METHOD FOR THE SYNTHESIS OF N-(PHOSPHONOMETHYL)GLYCINE | STRAITMARK HOLDING AG (CH) | 2017-05-03 | — | — | EP | disclosed |
| CN-104812763-B | For the method synthesizing N-((phosphonomethyl)) glycine | 斯特雷特马克控股股份公司 | 2016-11-23 | — | — | CN | disclosed |
| US-20160303882-A1 | INK SET AND THERMAL TRANSFER RECORDING SHEET | CANON KABUSHIKI KAISHA (JP) | 2016-10-20 | — | — | US | disclosed |
| US-20160185684-A1 | SELECTIVE OLEFIN METATHESIS WITH CYCLOMETALATED RUTHENIUM COMPLEXES | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2016-06-30 | — | — | US | disclosed |
| US-20160185821-A1 | Z-SELECTIVE OLEFIN METATHESIS OF PEPTIDES | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2016-06-30 | — | — | US | disclosed |
| WO-2016014954-A1 | TANDEM Z-SELECTIVE METATHESIS / DIHYDROXYLATION | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2016-01-28 | — | — | WO | disclosed |
| US-20150378273-A1 | YELLOW TONER AND PRODUCTION METHOD THEREFOR | CANON KABUSHIKI KAISHA (JP) | 2015-12-31 | — | — | US | disclosed |
| US-9198907-B2 | Combinations of a HCV inhibitor such as bicyclic pyrrole derivatives and a therapeutic agent | PTC THERAPEUTICS, INC. (US) | 2015-12-01 | — | — | US | disclosed |
| US-9150599-B2 | Method for the synthesis of N-(phosphonomethyl)glycine | STRAITMARK HOLDING AG (CH) | 2015-10-06 | — | — | US | disclosed |
| US-20150274700-A2 | DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF | YUHAN CORPORATION (KR) | 2015-10-01 | — | — | US | disclosed |
| EP-2049541-B1 | N-[5-({2-[(CYCLOPROPYLCARBONYL)AMINO]IMIDAZO[1,2-B]PYRIDAZIN-6-YL}OXY)-2-METHYLPHENYL]-1,3-DIMETHYL-1H-PYRAZOLE-5-CARBOXAMIDE AS VEGFR INHIBITOR | TAKEDA PHARMACEUTICAL (JP) | 2015-09-23 | — | — | EP | disclosed |
| CN-104812763-A | Method for synthesis of N-(phosphonomethyl)glycine | STRAITMARK HOLDING AG | 2015-07-29 | — | — | CN | disclosed |
| US-20150175635-A1 | METHOD FOR THE SYNTHESIS OF N-(PHOSPHONOMETHYL)GLYCINE | STRAITMARK HOLDING AG (CH) | 2015-06-25 | — | — | US | disclosed |
| EP-2875034-A1 | METHOD FOR THE SYNTHESIS OF N-(PHOSPHONOMETHYL)GLYCINE | Straitmark Holding AG (CH) | 2015-05-27 | — | — | EP | disclosed |
| US-8841302-B2 | HCV inhibitor and therapeutic agent combinations | PTC THERAPEUTICS, INC. (US) | 2014-09-23 | — | — | US | disclosed |
| CN-102414177-B | Compounds as bradykinin B1 antagonists | BOEHRINGER INGELHEIM INT | 2014-07-02 | — | — | CN | disclosed |
| EP-1968598-B1 | PYRIMIDINE-2,4-DIAMINES AND THEIR USES | RIGEL PHARMACEUTICALS INC (US) | 2014-02-19 | — | — | EP | disclosed |
| CN-103588718-A | Novel triazinedione derivatives as GABAB receptor modulators | ADDEX PHARMA SA | 2014-02-19 | — | — | CN | disclosed |
| WO-2014012988-A1 | METHOD FOR THE SYNTHESIS OF N-(PHOSPHONOMETHYL)GLYCINE | STRAITMARK HOLDING AG (CH) | 2014-01-23 | — | — | WO | disclosed |
| US-20130338179-A1 | DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF | YUHAN CORPORATION (KR) | 2013-12-19 | — | — | US | disclosed |
| CN-101679354-B | As GABABTriazinedione derivatives as receptor modulators | ADDEX PHARMA SA | 2013-12-18 | — | — | CN | disclosed |
| US-20130143858-A1 | COMPOUNDS AND THEIR USE AS IKACH BLOCKERS | ASTRAZENECA AB (SE) | 2013-06-06 | — | — | US | disclosed |
| US-20130131075-A1 | NEW COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-05-23 | — | — | US | disclosed |
| US-8361998-B2 | Compounds and their use as IKACh blockers | ASTRAZENECA AB | 2013-01-29 | — | — | US | disclosed |
| EP-2509961-A1 | IMIDAZOLIDINEDIONE DERIVATIVES | Autifony Therapeutics Limited (GB) | 2012-10-17 | — | — | EP | disclosed |
| US-8273741-B2 | Imidazo-pyridazinyl compounds and uses thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-09-25 | — | — | US | disclosed |
| WO-2012074469-A1 | NEW IKACH BLOCKERS | ASTRAZENECA AB (SE) | 2012-06-07 | — | — | WO | disclosed |
| US-20120142659-A1 | COMPOUNDS AND THEIR USE AS IKACH BLOCKERS | ASTRAZENECA AB (SE) | 2012-06-07 | — | — | US | disclosed |
| US-20120087893-A1 | COMBINATIONS OF A HCV INHIBITOR SUCH AS BICYCLIC PYRROLE DERIVATIVES AND A THERAPEUTIC AGENT | PTC THERAPEUTICS, INC. (US) | 2012-04-12 | — | — | US | disclosed |
| CN-102414177-A | Compounds as bradykinin b1 antagonists | BOEHRINGER INGELHEIM INT | 2012-04-11 | — | — | CN | disclosed |
| US-8153682-B2 | Sulfonamides as TRPM8 modulators | JANSSEN PHARMACEUTICA, NV (BE) | 2012-04-10 | — | — | US | disclosed |
| US-20120070412-A1 | HCV Inhibitor and Therapeutic Agent Combinations | PTC THERAPEUTICS, INC. (US) | 2012-03-22 | — | — | US | disclosed |
| US-8084615-B2 | Antibacterial agents | UNIVERSITY OF WASHINGTON (US) | 2011-12-27 | — | — | US | disclosed |
| US-8044049-B2 | Fused heterocyclic derivative and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-10-25 | — | — | US | disclosed |
| US-8034812-B2 | Imidazopyridazine derivative having kinase inhibitory activity and pharmaceutical agent thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-10-11 | — | — | US | disclosed |
| EP-2351827-A1 | Culture medium for cell growth and transfection | Life Technologies Corporation (US) | 2011-08-03 | — | — | EP | disclosed |
| WO-2011084991-A2 | FLUORINATED HDAC INHIBITORS AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2011-07-14 | — | — | WO | disclosed |
| WO-2011069951-A1 | IMIDAZOLIDINEDIONE DERIVATIVES | GLAXO GROUP LIMITED (GB) | 2011-06-16 | — | — | WO | disclosed |
| US-20110104076-A1 | Compositions, Methods For Preparing Amino Acids And Nuclear Magnetic Resonance Spectroscopy | GLYCONIX CORPORATION | 2011-05-05 | — | — | US | disclosed |
| US-20100311757-A1 | Salarins And Tulearins, Compositions And Uses Thereof | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2010-12-09 | — | — | US | disclosed |
| US-20100273788-A1 | FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-10-28 | — | — | US | disclosed |
| WO-2010107739-A2 | METHODS AND COMPOSITIONS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2010-09-23 | — | — | WO | disclosed |
| WO-2010107742-A2 | METHODS AND COMPOSITIONS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2010-09-23 | — | — | WO | disclosed |
| US-20100240669-A1 | NEW COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-09-23 | — | — | US | disclosed |
| US-20100168424-A1 | FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-07-01 | — | — | US | disclosed |
| EP-2200995-A2 | SALARINS AND TULEARINS, COMPOSITIONS AND USES THEREOF | Ramot at Tel-Aviv University Ltd (IL) | 2010-06-30 | — | — | EP | disclosed |
| US-7713987-B2 | Pyrimidine-2,4-diamines and their uses | RIGEL PHARMACEUTICALS, INC. (US) | 2010-05-11 | — | — | US | disclosed |
| CN-101679354-A | As GABABNovel triazinedione derivatives as receptor modulators | ADDEX PHARMACEUTICALS SA | 2010-03-24 | — | — | CN | disclosed |
| US-20090306374-A1 | FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-12-10 | — | — | US | disclosed |
| US-20090264474-A1 | SULFONAMIDES AS TRPM8 MODULATORS | JANSSEN PHARMACEUTICA, N.V. (BE) | 2009-10-22 | — | — | US | disclosed |
| CN-101541801-A | Fused heterocyclic derivative and use thereof | TAKEDA PHARMACEUTICAL (JP) | 2009-09-23 | — | — | CN | disclosed |
| EP-1268443-B1 | 2-HYDROXY-MUTILIN CARBAMATE DERIVATIVES FOR ANTIBACTERIAL USE | SMITHKLINE BEECHAM PLC (GB) | 2009-07-29 | — | — | EP | disclosed |
| US-20090163496-A1 | ANTIBACTERIAL AGENTS | UNIVERSITY OF WASHINGTON (US) | 2009-06-25 | — | — | US | disclosed |
| US-20090137595-A1 | FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-05-28 | — | — | US | disclosed |
| CN-101426785-A | Adenosine A3 receptor agonists | NOVARTIS AG (CH) | 2009-05-06 | — | — | CN | disclosed |
| EP-2049541-A2 | FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2009-04-22 | — | — | EP | disclosed |
| WO-2009040817-A2 | SALARINS AND TULEARINS, COMPOSITIONS AND USES THEREOF | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2009-04-02 | — | — | WO | disclosed |
| WO-2009039248-A2 | METHODS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION AND COMPOSITIONS FOR TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION | STANFORD UNIVERSITY (US) | 2009-03-26 | — | — | WO | disclosed |
| WO-2009039246-A2 | METHODS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION, COMPOSITIONS FOR TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION, AND SCREENING ASSAYS FOR IDENTIFYING COMPOSITIONS FOR TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION | STANFORD UNIVERSITY (US) | 2009-03-26 | — | — | WO | disclosed |
| US-20080275112-A1 | Invention Concerning Aminoadamantane Compounds | SCHREINER PETER R | 2008-11-06 | — | — | US | disclosed |
| US-7446109-B2 | Carbonylamino-derivatives as novel inhibitors of histone deacetylase | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-11-04 | — | — | US | disclosed |
| US-7446109-B2 | Carbonylamino-derivatives as novel inhibitors of histone deacetylase | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-11-04 | — | — | US | disclosed |
| EP-1968598-A1 | PYRIMIDINE-2,4-DIAMINES AND THEIR USES | Rigel Pharmaceuticals, Inc. (US) | 2008-09-17 | — | — | EP | disclosed |
| WO-2008088303-A1 | PYRIMIDINE-2,4-DIAMINES AND THEIR USES | RIGEL, PHARMACEUTICALS, INC. (US) | 2008-07-24 | — | — | WO | disclosed |
| EP-1942888-A2 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | Cytokinetics, Inc. (US) | 2008-07-16 | — | — | EP | disclosed |
| EP-1248612-B1 | NOVEL COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS | MERCK FROSST CANADA LTD (CA) | 2008-02-27 | — | — | EP | disclosed |
| WO-2008016192-A2 | FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-02-07 | — | — | WO | disclosed |
| CN-101039701-A | Prodrugs and codrug comprising a biocleavable disulfide linker | NICHOLAS PIRAMAL INDIA LTD (IN) | 2007-09-19 | — | — | CN | disclosed |
| US-20070161681-A1 | ETHER DERIVATIVES USEFUL AS INHIBITORS OF PDE4 ISOZYMES | PFIZER INC. (US) | 2007-07-12 | — | — | US | disclosed |
| WO-2007070195-A2 | COMPOSITIONS, METHODS OF PREPARING AMINO ACIDS AND NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY | GLYCONIX CORPORATION (US) | 2007-06-21 | — | — | WO | disclosed |
| US-20070129362-A1 | Pyrimidine-2,4-diamines and their uses | MIDCAP FINANCIAL TRUST | 2007-06-07 | — | — | US | disclosed |
| US-20070129360-A1 | N2-Chlorocarbonyl-N4-(2,2-dimethyl-3-oxo-4H-5-pyrido[1,4]oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine; kinase inhibitors; breast cancer; inhibiting signal transduction cascades in which Syk plays a role | PHAMIDIPATI SOMASEKHAR | 2007-06-07 | — | — | US | disclosed |
| WO-2007056078-A2 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | CYTOKINETICS, INC. (US) | 2007-05-18 | — | — | WO | disclosed |
| CN-1315929-C | Rubber composition for tread and pneumatic tyre using the same | SUMITOMO RUBBER IND (JP) | 2007-05-16 | — | — | CN | disclosed |
| US-20070104648-A1 | Compositions, methods of preparing amino acids, and nuclear magnetic resonance spectroscopy | GLYCONIX CORPORATION | 2007-05-10 | — | — | US | disclosed |
| US-7183293-B2 | Ether derivatives useful as inhibitors of PDE4 isozymes | PFIZER INC. (US) | 2007-02-27 | — | — | US | disclosed |
| CN-1832936-A | Processes for the preparation of n-((((pyridinyloxy)-phenylamino)quinazolinyl)-allyl)acetamide derivatives and related compounds as well as intermediates of such processes and processes for the prepar | PFIZER PROD INC (US) | 2006-09-13 | — | — | CN | disclosed |
| CN-1245979-C | Medicine for preventing and treating dermatitis containing chymase inhibitor as active ingredient | DAIICHI ASBIAO PHARMACEUTICAL (JP) | 2006-03-22 | — | — | CN | disclosed |
| CN-1245978-C | Preventive and therapeutic agent for various diseases associated with eosinophilia comprising chymase inhibitor as active ingredient | DAIICHI ASBIAO PHARMACEUTICAL (JP) | 2006-03-22 | — | — | CN | disclosed |
| EP-1248612-A4 | NOVEL COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS | MERCK FROSST CANADA INC (CA) | 2005-09-07 | — | — | EP | disclosed |
| CN-1216872-C | Quinazoline derivative and pharmaceutical use thereof | SUNTORY LTD (JP) | 2005-08-31 | — | — | CN | disclosed |
| CN-1643158-A | Process for preparing optically active beta-aminocarboxylic acids from racemic N-acylated beta-aminocarboxylic acids | DEGUSSA (DE) | 2005-07-20 | — | — | CN | disclosed |
| US-20050153401-A1 | Process for preparing optically active beta-aminocarboxylic acids from racemic n-acylated beta-aminocarboxylic acids | DEGUSSA AG (DE) | 2005-07-14 | — | — | US | disclosed |
| US-20050124652-A1 | Guanidino compounds | BOYCE RUSTUM (US) | 2005-06-09 | — | — | US | disclosed |
| CN-1572825-A | Rubber composition for tread and pneumatic tyre using the same | SUMITOMO RUBBER IND (JP) | 2005-02-02 | — | — | CN | disclosed |
| EP-1487990-A2 | PROCESS FOR PREPARING OPTICALLY ACTIVE BETA-AMINOCARBOXYLIC ACIDS FROM RACEMIC N-ACYLATED BETA-AMINOCARBOXYLIC ACIDS | Degussa AG (DE) | 2004-12-22 | — | — | EP | disclosed |
| EP-1399420-A2 | PYRROLIDINES AS DIPEPTIDYL PEPTIDASE INHIBITORS | SmithKline Beecham Corporation (US) | 2004-03-24 | — | — | EP | disclosed |
| WO-2003080854-A2 | PROCESS FOR PREPARING OPTICALLY ACTIVE BETA-AMINOCARBOXYLIC ACIDS FROM RACEMIC N-ACYLATED BETA-AMINOCARBOXYLIC ACIDS | DEGUSSA AG (DE) | 2003-10-02 | — | — | WO | disclosed |
| EP-0874809-B1 | CARBAMOYLOXY DERIVATIVES OF MUTILINE AND THEIR USE AS ANTIBACTERIALS | SMITHKLINE BEECHAM PLC (GB) | 2003-08-27 | — | — | EP | disclosed |
| EP-1329160-A2 | 4-ACYLAMINOPYRAZOLE DERIVATIVES | Sankyo Company, Limited (JP) | 2003-07-23 | — | — | EP | disclosed |
| EP-0733645-B1 | NOVEL SYNTHETIC PEPTIDE, LUNG SURFACTANT CONTAINING THE SAME, AND REMEDY FOR RESPIRATORY DISTRESS SYNDROME | MITSUBISHI PHARMA CORP (JP) | 2003-03-19 | — | — | EP | disclosed |
| US-6525036-B2 | Treating post-menopausal osteoporosis. | MERCK & CO., INC. | 2003-02-25 | — | — | US | disclosed |
| WO-2003002530-A2 | PYRROLIDINES AS DIPEPTIDYL PEPTIDASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2003-01-09 | — | — | WO | disclosed |
| EP-1248612-A1 | NOVEL COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS | MERCK FROSST CANADA INC. (CA) | 2002-10-16 | — | — | EP | disclosed |
| CN-1366461-A | Preventive or therapeutic drugs for dermatitises containing chymase inhibitors as active ingredient | SUNTORY LTD (JP) | 2002-08-28 | — | — | CN | disclosed |
| CN-1366459-A | Preventive and therapeutic agent for various diseases associated with eosinophilia comprising chymase inhibitor as active ingredient | SUNTORY LTD (JP) | 2002-08-28 | — | — | CN | disclosed |
| CN-1366460-A | Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as active ingredient | SUNTORY LTD (JP) | 2002-08-28 | — | — | CN | disclosed |
| US-20020052378-A1 | Novel compounds and compositions as protease inhibitors | Celera Corporation | 2002-05-02 | — | — | US | disclosed |
| CN-1335778-A | Blood vessel lipid deposition inhibitor containing chymotrypsin inhibitor | SUNTORY LTD (JP) | 2002-02-13 | — | — | CN | disclosed |
| EP-1175209-A2 | USE OF ANTIEPILEPTICS FOR TREATING RESPIRATORY DISORDERS, IN PARTICULAR ASTHMATIC DISORDERS | Lomia, Merab (GE) | 2002-01-30 | — | — | EP | disclosed |
| WO-2001049288-A9 | NOVEL COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS | MERCK FROSST CANADA INC (CA) | 2001-10-25 | — | — | WO | disclosed |
| CN-1319096-A | Quinazoline derivative and pharmaceutical use thereof | SUNTORY LTD (JP) | 2001-10-24 | — | — | CN | disclosed |
| WO-2001049288-A1 | NOVEL COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS | MERCK FROSST CANADA & CO. (CA) | 2001-07-12 | — | — | WO | disclosed |
| US-6239175-B1 | Carbamoyloxy derivatives of mutiline and their use as antibacterials | SMITHKLINE BEECHAM P.L.C. (GB) | 2001-05-29 | — | — | US | disclosed |
| WO-2000066096-A2 | USE OF ANTIEPILEPTICS FOR TREATING RESPIRATORY DISORDERS, IN PARTICULAR ASTHMATIC DISORDERS | LOMIA MERAB (GE) | 2000-11-09 | — | — | WO | disclosed |
| US-6114163-A | ACETYLATING RACEMIC MIXTURE, NEUTRALIZING SOLUTION, DEACETYLING USING STEREOSPECIFIC ACYLASE TO PRODUCE L-STEREOISOMERS, SEPARATING OUT WANTED PRODUCT, ADJUSTING SOLUTION, RACEMIZING MIXTURE, AND DEACETYLATING AGAIN | DEGUSSA AKTIENGESELLSCHAFT (DE) | 2000-09-05 | — | — | US | disclosed |
| US-6080887-A | HEATING A MIXTURE COMPRISING THE RACEMIC MIXTURE WITH AT LEAST ONE ALKALI OR ALKALINE EARTH SALT OF N-ACETYL-D(L)-.ALPHA.-AMINO CARBOXYLIC ACID AND ACETIC ANHYDRIDE UNDER NON-AQUEOUS CONDITIONS | DEGUSSA AKTIENGESELLSCHAFT (DE) | 2000-06-27 | — | — | US | disclosed |
| EP-0487301-B1 | Method of stabilizing enzyme conjugates | DADE BEHRING MARBURG GMBH (DE) | 2000-05-31 | — | — | EP | disclosed |
| US-6020368-A | MICROBIOCIDES | HINKS JEREMY DAVID (US) | 2000-02-01 | — | — | US | disclosed |
| EP-0924263-B1 | Disazo dyes, their preparation and use thereof | ILFORD IMAGING CH GMBH (CH) | 1999-07-28 | — | — | EP | disclosed |
| JP-H11180801-A | PLANT FRESHNESS MAINTAINING AGENT AND PLANT TREATED WITH THE AGENT AFTER HARVEST | DAIWA KASEI KENKYUSHO:KK | 1999-07-06 | — | — | JP | disclosed |
| EP-0924263-A1 | Disazo dyes, their preparation and use thereof | ILFORD Imaging Switzerland GmbH (CH) | 1999-06-23 | — | — | EP | disclosed |
| EP-0874809-A1 | CARBAMOYLOXY DERIVATIVES OF MUTILINE AND THEIR USE AS ANTIBACTERIALS | SMITHKLINE BEECHAM PLC (GB) | 1998-11-04 | — | — | EP | disclosed |
| US-5827825-A | POLYPEPTIDE FROM THE CONDENSATION OF VARIABLE HEXA- OR HEPTAPEPTIDES WITH PEPTIDES CONTAINING TWELVE TO TWENTY UNITS OF LEUCINE AND/OR NORLEUCINE, FOR TREATMENT OF RESPIRATORY DISORDERS | TOKYO TANABE COMPANY LTD. (JP) | 1998-10-27 | — | — | US | disclosed |
| US-5686253-A | Method of stabilizing enzyme conjugates | BEHRINGWERKE AG (DE) | 1997-11-11 | — | — | US | disclosed |
| WO-1997025309-A1 | CARBAMOYLOXY DERIVATIVES OF MUTILINE AND THEIR USE AS ANTIBACTERIALS | SMITHKLINE BEECHAM PLC (GB) | 1997-07-17 | — | — | WO | disclosed |
| US-5614351-A | Radiation-curable mixture, and radiation-sensitive recording material produced therefrom for high-energy radiation | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-03-25 | — | — | US | disclosed |
| EP-0733645-A1 | NOVEL SYNTHETIC PEPTIDE, LUNG SURFACTANT CONTAINING THE SAME, AND REMEDY FOR RESPIRATORY DISTRESS SYNDROME | TOKYO TANABE COMPANY LIMITED (JP) | 1996-09-25 | — | — | EP | disclosed |
| EP-0300665-B1 | Cephalosporin compounds, process for their preparation and their pharmaceutical compositions | ZENECA PHARMA SA (FR) | 1995-12-20 | — | — | EP | disclosed |
| EP-0304155-B1 | Cephalosporin compounds, process for their preparation and their pharmaceutical compositions | ZENECA PHARMA SA (FR) | 1995-11-15 | — | — | EP | disclosed |
| US-5254679-A | Containing a quaternized nitrogen | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-10-19 | — | — | US | disclosed |
| US-5212069-A | Forming dipeptides from amides and glycine, cysteine or methionine | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1993-05-18 | — | — | US | disclosed |
| US-5210202-A | Chiral phosphorous compounds, a process for their manufacture and their application to the catalysis of enantioselective synthesis reactions | SOCIETE CHIMIQUE DES CHARBONNAGES S.A. (FR) | 1993-05-11 | — | — | US | disclosed |
| EP-0225182-B1 | CEPHALOSPORIN COMPOUNDS | ICI PHARMA (FR) | 1993-02-10 | — | — | EP | disclosed |
| US-5134073-A | Culture product of zoogloea ramigera | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1992-07-28 | — | — | US | disclosed |
| EP-0487301-A1 | Method of stabilizing enzyme conjugates | BEHRINGWERKE Aktiengesellschaft (DE) | 1992-05-27 | — | — | EP | disclosed |
| US-5099077-A | Dihydrocarbylphosphioxy substituted groups with amine or phosphinoamines as ligands | SOCIETE CHIMIQUE DES CHARBONNAGES S.A. (FR) | 1992-03-24 | — | — | US | disclosed |
| US-5049558-A | Quaternized nitrogen-heterocycle substituted | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1991-09-17 | — | — | US | disclosed |
| US-5013731-A | Bactericides | ICI PHARMA (FR) | 1991-05-07 | — | — | US | disclosed |
| US-5013730-A | Antibiotics | ICI-PHARMA (FR) | 1991-05-07 | — | — | US | disclosed |
| US-5008258-A | Antibiotics | I.C.I.-PHARMA (FR) | 1991-04-16 | — | — | US | disclosed |
| EP-0164944-B1 | CEPHALOSPORIN DERIVATIVES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1990-07-11 | — | — | EP | disclosed |
| EP-0374415-A2 | Thickening agents for aqueous surfactant compositions | HÜLS AKTIENGESELLSCHAFT (DE) | 1990-06-27 | — | — | EP | disclosed |
| EP-0374414-A2 | Use of thickener compositions for surfactants and surfactant systems | HÜLS AKTIENGESELLSCHAFT (DE) | 1990-06-27 | — | — | EP | disclosed |
| US-4909916-A | Method of working up the solution from the enzymatic resolution of a racemate of an N-acetyl-DL-amino-carboxylic acid | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1990-03-20 | — | — | US | disclosed |
| US-4909916-A | Method of working up the solution from the enzymatic resolution of a racemate of an N-acetyl-DL-amino-carboxylic acid | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1990-03-20 | — | — | US | disclosed |
| US-4909916-A | Method of working up the solution from the enzymatic resolution of a racemate of an N-acetyl-DL-amino-carboxylic acid | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1990-03-20 | — | — | US | disclosed |
| US-4877908-A | Chiral phosphorus compounds, a process for their manufacture and their application to the catalysis of enantioselective synthesis reactions | NORSOLOR (FR) | 1989-10-31 | — | — | US | disclosed |
| EP-0232486-B1 | PROCESS FOR REPROCESSING THE SOLUTION WHICH IS LEFT AFTER THE REMOVAL OF THE ENZYMES UPON THE ENZYMATIC RACEMATIC SPLITTING OF AN N-ACETYL-DL-AMINO ACID IN THE PRESENCE OF AN L-AMINO ACID ACYLASE | Degussa Aktiengesellschaft (DE) | 1989-09-06 | — | — | EP | disclosed |
| EP-0304155-A2 | Cephalosporin compounds, process for their preparation and their pharmaceutical compositions | ZENECA Pharma S.A. (FR) | 1989-02-22 | — | — | EP | disclosed |
| EP-0300664-A2 | Cephalosporin compounds | ZENECA Pharma S.A. (FR) | 1989-01-25 | — | — | EP | disclosed |
| EP-0300665-A2 | Cephalosporin compounds, process for their preparation and their pharmaceutical compositions | ZENECA Pharma S.A. (FR) | 1989-01-25 | — | — | EP | disclosed |
| US-4699999-A | REMOVAL OF COBALT CATALYSTS BY NEUTRALIZATION | DYNAMIT NOBEL AG (DE) | 1987-10-13 | — | — | US | disclosed |
| US-4592774-A | Herbicidal alpha heterocyclic carbinol carbamates, ureas and N-alpha-substituted acetylcarbamates | UNION CARBIDE CORPORATION (US) | 1986-06-03 | — | — | US | disclosed |
| US-4592774-A | Herbicidal alpha heterocyclic carbinol carbamates, ureas and N-alpha-substituted acetylcarbamates | UNION CARBIDE CORPORATION (US) | 1986-06-03 | — | — | US | disclosed |
| US-4592774-A | Herbicidal alpha heterocyclic carbinol carbamates, ureas and N-alpha-substituted acetylcarbamates | UNION CARBIDE CORPORATION (US) | 1986-06-03 | — | — | US | disclosed |
| EP-0164944-A1 | Cephalosporin derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1985-12-18 | — | — | EP | disclosed |
| US-4410522-A | BACTERICIDES | TOYAMA CHEMICAL CO., LTD. (JP) | 1983-10-18 | — | — | US | disclosed |
| US-4379152-A | Cephalosporins | TOYAMA CHEMICAL CO., LTD. (JP) | 1983-04-05 | — | — | US | disclosed |
| US-4327097-A | BACTERICIDES FOR MAMMALS | TOYAMA CHEMICAL CO., LTD. (JP) | 1982-04-27 | — | — | US | disclosed |
| US-4234578-A | ANTIBIOTICS | CIBA-GEIGY CORPORATION (US) | 1980-11-18 | — | — | US | disclosed |
| US-4219554-A | Novel penicillins and cephalosporins and process for producing same | TOYAMA CHEMICAL COMPANY, LIMITED (JP) | 1980-08-26 | — | — | US | disclosed |
| US-4112090-A | BACTERICIDE | TOYAMA CHEMICAL CO., LTD. (JP) | 1978-09-05 | — | — | US | disclosed |
| US-4110327-A | BACTERICIDES | TOYAMA CHEMICAL CO., LTD. (JP) | 1978-08-29 | — | — | US | disclosed |
| US-4087424-A | Novel penicillins and cephalosporins and process for producing the same | TOYAMA CHEMICAL CO., LTD. (JA) | 1978-05-02 | — | — | US | disclosed |
| US-4005088-A | Process for the chemical separation of racemic modifications of α-aminocarboxylic acid derivatives, and cinchonidine salt intermediates | ANDENO B.V. (NL) | 1977-01-25 | — | — | US | disclosed |
| US-4005088-A | Process for the chemical separation of racemic modifications of α-aminocarboxylic acid derivatives, and cinchonidine salt intermediates | ANDENO B.V. (NL) | 1977-01-25 | — | — | US | disclosed |